Purpose: The aim of this project was to design and manufacture a cost-effective end-to-end (E2E) phantom for quantifying the geometric and dosimetric accuracy of a linear accelerator based, multi-target single-isocenter (MTSI) frameless stereotactic radiosurgery (SRS) technique.
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| INTRODUCTION
Intracranial metastases are being discovered in approximately 400,000 patients per year worldwide, 1 of which about 70-80% will have multiple intracranial metastases. 2 The role of linear accelerator based stereotactic radiosurgery (SRS) in treatment of these intracranial metastases has expanded significantly in past decades, due to its high delivery efficiency 3 and equivalent plan quality, 4 relative to Gamma Knife (GK) radiosurgery.
Recent published data indicates that due to the relatively high toxicity and poor neurological outcomes associated with whole brain radiotherapy, SRS is now becoming the standard of care in the treatment of patients with multiple brain metastases. [5] [6] [7] The role of SRS has recently expanded to include treatment of multiple cranial metastases with a single isocenter, 8, 9 hence further reducing treatment times. This technique requires the use of multi-leaf collimators (MLCs) and volumetric modulated arc therapy (VMAT) or dynamic conformal arc therapy (DCAT), as cone collimation can treat only one target at a time.
Another recent change in technique has been the use of onboard imaging, such as cone beam computed tomography (CBCT) facility on the linear accelerator. Rather than relying on a separate kV X-ray imaging system, CBCT is used to position the patient for SRS. This requires much tighter tolerances for the linear accelerator isocenter and CBCT geometric accuracy compared to non-SRS treatments.
To meet the growing demand, there is a need for SRS treatments to be available in most radiation oncology departments rather than remain confined to specialist centers. This creates a challenge for staff in departments who do not have SRS experience or the appropriate equipment, to meet the strict demands on geometric and dosimetric accuracies required for the multi-target single-isocenter (MTSI) SRS technique.
An essential element of setting up and maintaining an SRS program is quantifying the uncertainties inherent in the planning and treatment process. These factors include, but are not limited to, uncertainties due to systematic, and/or random errors in: gross tumour volume (GTV) contouring, 10 geometric distortion of magnetic resonance imaging (MRI) used for contouring of GTVs, 11 the image registration of MRI and CT images used for treatment planning, 12 the measurement of small field data, 13 the treatment planning system (TPS) modeling of small field sizes, 14 differences in the treatment and imaging isocenters of the linear accelerator, 15 patient positioning after CBCT, 15 and intrafraction motion of the patient during treatment delivery. 16 The aim of end to end (E2E) testing is to measure the overall geometric and dosimetric accuracy of the planning and treatment 
| MATERIALS AND METHODS

2.A | Phantom design
The phantom is a Perspex cylinder of diameter 150 mm and length 255 mm. The central portion of the phantom is made up of Perspex inserts (20 × 20 × 220 mm) to allow for placement of dosimeters and fiducial markers, to aid in the SRS E2E testing process (Fig. 1) .
The size and shape of the MTSI phantom without the ArcCheck is ideal for MTSI SRS E2E testing as it closely mimics the size and shape of an average adult head and allows for a thermoplastic mask to be fitted to the phantom to provide a true E2E test incorporating all relevant equipment. Minor modifications were made to the phantom, e.g., removal of the metal handle and threaded inserts to avoid Other inserts used for the E2E testing were made in-house: five 
2.B | Treatment planning approach 2.B.1 | Imaging
The phantom was initially scanned using a 3T Philips Achieva MRI scanner with a T1 weighted, 1 mm slice thickness MRI scan protocol.
To provide fiducial markers for assessment of MRI distortion and MRI/CT image fusion accuracy, the five vitamin E inserts [shown in From the MRI scan, the distances between the centroids of each vitamin E capsule were measured in the treatment planning system and compared to the known distances (within the mechincal uncertainty of ±0.2 mm) to quantify the effects of any image distortion across the range of the entire image. The average, standard deviation, and root mean squared (RMS) errors were calculated for each direction independently.
The phantom was placed within a QFix Encompass SRS headboard (Type RT-4600-01, QFix, Avondale, PA) and mask system (Type RT-B889KYCF2, QFix, Avondale, PA), the same system to be used for patient localization during the SRS treatment planning and delivery process in our department (Fig. 3) . The phantom was then scanned with 1 mm slice thickness on a dedicated radiotherapy Philips Big Bore CT scanner with the vitamin E inserts in the same configuration as the MRI, along with four bone inserts as shown in Fig. 4 . The setup and CT scan of the phantom, as well as construction of the mask was performed by radiation therapists, to mimic the F I G . 3. MTSI SRS E2E phantom placed inside the QFix Encompass SRS headboard and mask system.
Axial CT slice indicating orientation of bone inserts in E2E phantom.
true patient simulation as closely as possible. The scan was exported to the image registration software platform.
2.B.2 | Registration MRI-CT
The MRI scan was registered to the CT using a manual rigid registra- 
2.B.3 | Treatment plans
To perform the dosimetric validation of the technique, several MTSI SRS treatment plans were created on the CT scan using the Pinnacle TPS (v9.10, Philips, Fitchburg, WI). A total of 10 SRS plans were created on the CT scan consisting of 1-4 spherical isocentric or non-isocentric target volumes (Table 1) . A volumetric modulated arc therapy (VMAT) plan technique was used within the SmartArc module of Pinnacle with the collapsed-cone convolution algorithm 19 to create the plans, following the University of Alabama MTSI SRS treatment planning protocol that has been described previously. 
2.B.4 | Phantom setup and image guidance
For each plan, the phantom was placed in the dedicated SRS headboard and mask system by the radiation therapists and initially aligned using the lasers and the reference marks that were placed on the mask system at CT simulation. A CBCT was then performed and the phantom aligned to the reference CT scan using a bone window 
2.B.5 | Off-axis WLT
Prior to the CBCT match, the ball bearing (BB) insert was placed in the phantom at so that a BB was aligned to the target location as defined by the treatment plan described in Section 2.B.3. A multileaf collimator (MLC) defined 2 × 2 cm field size was created with the collimator jaws set to 3 × 3 cm, centerd on the target in the TPS. After the CBCT match, the MLC field was delivered and image captured on an electronic portal imaging device (EPID) for each combination of gantry, collimator, and couch angles outlined in Table 2 . 
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The BB position relative to the field center was then calculated using the DoseLabPro software package (v6.40, Mobius Medical Systems, Redwood City, CA). This procedure was repeated for each of the targets in the treatment plans.
2.B.6 | Point dose measurements
Following the CBCT setup and off-axis WLT, point dose measurements were performed on the treatment plan with a PTW PinPoint3D ionization chamber with a dedicated insert [ Fig. 2(a) ]. The center of the chamber sensitive volume was placed at the center of the target as defined in the TPS. A region of interest was created in the TPS with identical volume to that of the PTW PinPoint3D ionization chamber, centerd on the point of interest. The average computed dose in this volume was compared to the measured point doses with a tolerance of 5%.
2.B.7 | Planar dose measurements
2D planar dose measurements were performed using Gafchromic EBT3 film (Ashland Inc., Wayne, NJ, USA) of size 125 × 165 mm.
Planar doses were measured through the center of each target and compared to those predicted by the TPS, using gamma analysis. 20 A tolerance of 3% global dose difference and 1 mm distance to agreement was employed (excluding dose points below a 10% threshold) with a minimum pass rate of 95% considered acceptable.
EBT3 films were scanned in an Epson 10000XL flatbed scanner (SEIKO Epson Co, Japan). The films were positioned on the scanner with a jig to ensure reproducible positioning of the film within the scanning area, and placed under a sheet of glass during scanning to maintain good contact between the film and the scanner as recommended by Ashland. 21 The films were scanned 24 h after exposure to allow stabilization of the latent image. 22 Each film was scanned in transmission mode using 48 bit RGB with a scanner resolution of 75 dpi (0.34 mm pixel size). All phantom and calibration film pieces were marked in order to maintain the same orientation during scanning, thereby eliminating polarization effects, 23 and positioned at the center of the flatbed scanner with the long axis of the film pieces parallel to the long axis of the scanner to avoid off-axis scanner non-uniformity. 24 The pixel values measured from the red channel of the scanner were used to calculate the optical density (OD) for each film piece and these were converted to absorbed dose (in cGy) using a OD-to-dose calibration curve.
| RESULTS
3.A | MRI distortion
The 
3.B | MRI/CT fusion
The average (±1 SD) MRI/CT fusion error was measured in MIM as 
3.C. | Phantom setup and CBCT alignment
Phantom setup and CBCT alignment results are summarized in Tables 3 and 4 , for translations and rotations, respectively. As can be seen from the tables, after CBCT based correction using a 6DOF couch, the residual translation and rotation errors after repeat CBCT are 0.2 mm and 0.1°, respectively. Furthermore, the relatively minor initial corrections indicate that a reproducible setup of the phantom between simulation and treatment.
3.D | Off-axis WLT
The off-axis WLT results are summarized in Fig. 6 and Table 5, where the average displacement from the center of the BB to the T A B L E 2 Combination of gantry, collimator, and couch fields used for Winston-Lutz testing in this study. off-axis distance of 6 cm, the maximum deviation was 0.97 mm.
3.E | Dosimetric verification
3.E.1 | Point dose measurements
Measured point doses were systematically lower than those predicted by the TPS. For each of the 20 targets from the 10 SRS plans in the study, the average (±1 SD) difference between measured and TPS predicted dose was −1.9% ±1.4%. All of the targets fell within the 5% tolerance set prior to measurement, with the minimum difference measured as −0.1% and the maximum as −4.9%.
There was no trend observed with the point dose results when comparing to target size or number of targets in the plan. However, as seen in Table 6 , the difference between the measured and TPS predicted point doses was observed to get larger with increasing distance of the target away from the isocenter of the plan.
3.E.2 | Planar dose measurements
For each of the 20 targets from the 10 SRS plans in the study, the average (±1 SD) gamma pass rate for the planar dose verifications was 97.9% ± 1.1%. Each of the targets had a gamma pass rate greater than the 95% tolerance for the 3%/1 mm gamma criteria.
The maximum pass rate was 99.4% and the minimum was 95.5%. The methodology utilized in this study to measure the distortion of the MR image requires precise knowledge of the actual distances between the vitamin E capsules in the phantom. This in turn requires precise mechanical tolerances when constructing the inserts. As stated in the Results section, maximum difference between the known and MRI measured distances was comparable to known mechanical tolerance for our phantom. However, it is recommended that if mechanical tolerances less than 0.5 mm cannot be achieved inhouse, then construction of these inserts should be outsourced to a plastic cutting firm, preferably with laser cutting capability.
Analysis of the deviation between CBCT/MV isocenters (or Winston-Lutz) tests was also in agreement with other studies from the literature. Gao et al. 28 reported deviations between WLT errors of less than 1 mm up to 3 cm off-axis, and errors of up to 1.72 mm at an off-axis distance of 5 cm. However, that study was performed on a Varian 21EX linear accelerator and the WLT pointer was aligned mechanically to the lasers, rather than aligned using the CBCT isocenter as performed in this study. Another study performed by Song, et al. 29 performed an off-axis WLT using the same methodology as our study, on a Varian TrueBeam STx linear accelerator up to an off-axis distance up to 4 cm. The results were similar to those reported here, with maximum off-center errors of less than 1 mm.
As described by Gao et al., 28 the increasing deviation between the center of the mechanical and radiation fields with increasing off-axis distance may be due to the increasing effect of small rotational errors with increasing off-axis distance. Furthermore, at off-axis positions, the penumbra of the radiation field becomes asymmetric and the center of the radiation field becomes less well defined, an effect that is magnified with increasing off-axis distance.
Dosimetric accuracy of the treatment plans in this study was confirmed using both ionization chamber and Gafchromic film measurements. The Gafchromic film measurements confirmed measured vs TPS predicted doses to within 3%/1 mm, and the point dose verification measurements showed agreement with the TPS to within 5%. The measured point doses were observed to measure systematically less than the TPS predicted doses. Similar results using Gafchromic film have previously been reported in the literature for E2E dosimetric verification of SRS plans. 30, 31 Liu, et al. 30 reported gamma pass rates of greater than 99% for 3%/2 mm gamma criteria, and Dimitriadis, et al. 31 found an average gamma pass rate of 96.7% for 2%/2 mm gamma criteria. Planar dose verification measurements were observed to have decreasing gamma pass rates with increasing plan complexity.
The E2E phantom presented in this study includes rounding of the end through which the vertex fields enter the phantom. This modification was performed to more closely match the shape of the human head. However, the authors note that such modifications may not be possible for all departments who wish to mimic this study. Rounding of the end of the phantom is not required for VMAT treatments because the beam spends very little time entering Another limitation of the study is that intra-fraction motion was also not considered in the analysis. A study by Wen et al. 32 was performed with the same linear accelerator and immobilization system used in this study. Intra-fractional motion was assessed in the study using repeated two-dimensional kV imaging and optical surface monitoring systems (OSMS). The authors of the study presented excellent agreement between the two systems for the measured intra-fractional motion among their patient cohort. Average intra-fraction translations and rotations were measured to be approximately 0.5 mm and 0.5°, respectively. Data obtained from the first five patients treated with the SRS technique at our institution has resulted in similar intra-fraction translations and rotations to those quoted in the study.
Finally, only up to 4 target volumes were considered in any one plan. This limitation is one that has been implemented locally in our department, based on published randomized clinical trial data. [5] [6] [7] However, the authors are aware that it is common for departments to routinely treat more than 4 targets using MTSI plans and we believe that the technique presented in this paper can be easily extended to provide E2E testing for MTSI plans with more than 4 targets. Extension of the E2E technique to MTSI plans with more than 4 targets will be investigated in future studies.
| CONCLUSION
With the growing role of linear accelerators in treating brain metastases patients with SRS, the number of radiation oncology departments around the world providing an SRS service is likely to increase significantly. We have developed a novel and cost-effective solution for comprehensive E2E testing of these treatments that can incorporate multiple detector types and is easily adaptable to the specific workflows of these departments. The E2E test revealed that targets, even when located in non-isocentric positions, can consistently be located to within 1 mm using CBCT.
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